Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15552 | 706 | 29.8 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
233 | 2 | ACINETOBACTER BAUMANNII//EXTENDED SPECTRUM BETA LACTAMASE//ESBL | 20247 |
15552 | 1 | TIGECYCLINE//GLYCYLCYCLINE//GAR 936 | 706 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIGECYCLINE | authKW | 6234501 | 39% | 53% | 273 |
2 | GLYCYLCYCLINE | authKW | 1771174 | 8% | 69% | 59 |
3 | GAR 936 | authKW | 393179 | 1% | 91% | 10 |
4 | BROAD SPECTRUM ANTIBACTERIAL THERAPY | authKW | 259499 | 1% | 100% | 6 |
5 | GLYCYLCYCLINE ANTIBIOTICS | authKW | 222426 | 1% | 86% | 6 |
6 | WERNER FORSSMANN HOSP | address | 222426 | 1% | 86% | 6 |
7 | CLIN INTERNAL INTENS MED INTERDISCIPLINARY EMER | address | 216249 | 1% | 100% | 5 |
8 | NORTH HOSP AMIENS | address | 216249 | 1% | 100% | 5 |
9 | INFECT DIS DISCOVERY | address | 151368 | 1% | 50% | 7 |
10 | KAOHSIUNG MED INFECT DIS | address | 138398 | 1% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 15428 | 44% | 0% | 310 |
2 | Microbiology | 13693 | 58% | 0% | 407 |
3 | Pharmacology & Pharmacy | 6553 | 56% | 0% | 394 |
4 | Oncology | 46 | 6% | 0% | 45 |
5 | Chemistry, Medicinal | 38 | 3% | 0% | 21 |
6 | Immunology | 33 | 5% | 0% | 37 |
7 | Biotechnology & Applied Microbiology | 6 | 3% | 0% | 20 |
8 | Critical Care Medicine | 2 | 1% | 0% | 5 |
9 | Chemistry, Organic | 2 | 3% | 0% | 18 |
10 | Toxicology | 1 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | WERNER FORSSMANN HOSP | 222426 | 1% | 86% | 6 |
2 | CLIN INTERNAL INTENS MED INTERDISCIPLINARY EMER | 216249 | 1% | 100% | 5 |
3 | NORTH HOSP AMIENS | 216249 | 1% | 100% | 5 |
4 | INFECT DIS DISCOVERY | 151368 | 1% | 50% | 7 |
5 | KAOHSIUNG MED INFECT DIS | 138398 | 1% | 80% | 4 |
6 | PROC CHEM RD | 98290 | 1% | 45% | 5 |
7 | AFRICA MIDDLE EAST GULF LEVANT | 43250 | 0% | 100% | 1 |
8 | ATATUK TRAINING HOSP | 43250 | 0% | 100% | 1 |
9 | BANGALORE MED FT | 43250 | 0% | 100% | 1 |
10 | CRIT CARE MED 2 MED | 43250 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 29264 | 8% | 1% | 60 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 25516 | 17% | 1% | 118 |
3 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 23910 | 7% | 1% | 46 |
4 | JOURNAL OF CHEMOTHERAPY | 13673 | 4% | 1% | 28 |
5 | REVISTA ESPANOLA DE QUIMIOTERAPIA | 13295 | 2% | 3% | 11 |
6 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 12442 | 8% | 0% | 60 |
7 | JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE | 9364 | 1% | 3% | 7 |
8 | REVISTA CHILENA DE INFECTOLOGIA | 4616 | 1% | 1% | 9 |
9 | ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 3423 | 1% | 2% | 5 |
10 | MICROBIAL DRUG RESISTANCE | 2383 | 1% | 1% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POURNARAS, S , KOUMAKI, V , SPANAKIS, N , GENNIMATA, V , TSAKRIS, A , (2016) CURRENT PERSPECTIVES ON TIGECYCLINE RESISTANCE IN ENTEROBACTERIACEAE: SUSCEPTIBILITY TESTING ISSUES AND MECHANISMS OF RESISTANCE.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 48. ISSUE 1. P. 11 -18 | 80 | 73% | 3 |
2 | BARBERAN, J , SALSO, S , ALHAMBRA, A , (2015) TIGECYCLINE: 10 YEARS OF HISTORY AND STILL IN FULL FORCE.REVISTA ESPANOLA DE QUIMIOTERAPIA. VOL. 28. ISSUE 2. P. 61 -78 | 92 | 72% | 0 |
3 | KELESIDIS, T , KARAGEORGOPOULOS, DE , KELESIDIS, I , FALAGAS, ME , (2008) TIGECYCLINE FOR THE TREATMENT OF MULTIDRUG-RESISTANT ENTEROBACTERIACEAE: A SYSTEMATIC REVIEW OF THE EVIDENCE FROM MICROBIOLOGICAL AND CLINICAL STUDIES.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 62. ISSUE 5. P. 895 -904 | 57 | 78% | 81 |
4 | DOAN, TL , FUNG, HB , MEHTA, D , RISKA, PF , (2006) TIGECYCLINE: A GLYCYLCYCLINE ANTIMICROBIAL AGENT.CLINICAL THERAPEUTICS. VOL. 28. ISSUE 8. P. 1079-1106 | 57 | 83% | 75 |
5 | YAHAV, D , LADOR, A , PAUL, M , LEIBOVICI, L , (2011) EFFICACY AND SAFETY OF TIGECYCLINE: A SYSTEMATIC REVIEW AND META-ANALYSIS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 66. ISSUE 9. P. 1963-1971 | 36 | 86% | 117 |
6 | GIAMARELLOU, H , POULAKOU, G , (2011) PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF TIGECYCLINE.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 7. ISSUE 11. P. 1459 -1470 | 48 | 83% | 19 |
7 | STEIN, GE , BABINCHAK, T , (2013) TIGECYCLINE: AN UPDATE.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. VOL. 75. ISSUE 4. P. 331-336 | 40 | 82% | 37 |
8 | DE ROSA, FG , CORCIONE, S , DI PERRI, G , SCAGLIONE, F , (2015) RE-DEFINING TIGECYCLINE THERAPY.NEW MICROBIOLOGICA. VOL. 38. ISSUE 2. P. 121 -136 | 44 | 77% | 6 |
9 | FALAGAS, ME , KARAGEORGOPOULOS, DE , DIMOPOULOS, G , (2009) CLINICAL SIGNIFICANCE OF THE PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF TIGECYCLINE.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 1. P. 13 -21 | 50 | 75% | 22 |
10 | NICOLAU, DP , (2009) MANAGEMENT OF COMPLICATED INFECTIONS IN THE ERA OF ANTIMICROBIAL RESISTANCE: THE ROLE OF TIGECYCLINE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 10. ISSUE 7. P. 1213-1222 | 56 | 64% | 17 |
Classes with closest relation at Level 1 |